Expression of chromogranin A and B and secretoneurin immunoreactivity in neoplastic and nonneoplastic pancreatic alpha cells.
In the endocrine pancreas, chromogranins A and B as well as secretoneurin (a biologically active peptide processed endoproteolytically from secretogranin II) are most intensely expressed in alpha (glucagon) cells. We examined whether the functional status of neoplastic and nonneoplastic human alpha cells is reflected in the expression patterns of chromogranins/secretogranins. Neoplastic alpha cells were analysed immunocytochemically in six functioning glucagonomas and 37 nonfunctioning neuroendocrine tumours (29 with alpha cells) for their immunoreactivity to chromogranin A and B, as well as secretoneurin. There was no difference in the staining intensity for either peptide between glucagonomas and nonfunctioning, alpha cell containing tumours. Nonneoplastic alpha cells from patients with a functioning glucagonoma showed a decreased glucagon immunoreactivity, whereas the expression of chromogranin A (but not chromogranin B and secretoneurin) was as intense as in alpha cells not associated with glucagonoma syndrome. These results suggest that the expression of chromogranins/secretogranins in neoplastic alpha cells of the pancreas may be independently regulated from the cells' functional status. In nonneoplastic alpha cells there seems to be an association between glucagon production and chromogranin B and secretoneurin expression.
Department of Pathology, University of Münster, Westfalia, Germany.
K W
KW
Schmid
M
M
Brink
G
G
Freytag
R
R
Kirchmair
W
W
Böcker
R
R
Fischer-Colbrie
P U
PU
Heitz
G
G
Klöppel
D000911:Antibodies, Monoclonal; D053379:Chromogranin A; D002864:Chromogranins / Q000032:analysis*; D005934:Glucagon / Q000032:analysis; D005935:Glucagonoma / Q000737:chemistry*; D006801:Humans; D007124:Immunoenzyme Techniques; D007515:Islets of Langerhans / Q000737:chemistry* / Q000166:cytology; D018358:Neuroendocrine Tumors / Q000737:chemistry*; D009479:Neuropeptides / Q000032:analysis*; D010190:Pancreatic Neoplasms / Q000737:chemistry*; D010257:Paraneoplastic Syndromes / Q000378:metabolism; D053381:Secretogranin II
D000911:Antibodies, Monoclonal; C506150:CHGA protein, human; D053379:Chromogranin A; D002864:Chromogranins; D009479:Neuropeptides; D053381:Secretogranin II; C081159:secretoneurin; D005934:Glucagon